Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™

Clinical trial NCT01641133 · COMPLETED

Trial details

NCT number: NCT01641133
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Streptococcal Streptococcus Pneumoniae Vaccines

Start date: 2012-09-04
Primary completion: 2013-07-15
Enrollment: 457

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.